| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00580190 Details | 2009-09-14 Interventional | 1 | 47 | Alprazolam Healthy | Date of termination was Feb. 7, 2008. Reasons of termination were due to elevation of liver
function tests and long elimination half-life of the compound. - | |||
| NCT00788515 2008-001492-30 Details | 2009-08-28 Interventional | 3 | 33 | Lormetazepam Volinanserin Sleep Initiatio… | Sponsor's decision due to absence of demonstration of efficacy of volinanserin in primary
insomnia with predominant sleep maintenance problems - | |||
| NCT00132951 Details | 2009-08-27 Interventional | 4 | 2051 | Azithromycin Telithromycin Bronchitis Bronchitis, Chr… Communicable Di… Infections Respiratory Tra… Chronic Bronchi… Pneumonia | - - | |||
| NCT00505089 Details | 2009-08-25 Interventional | 1/2 | 11 | Antibodies, Mon… Arthritis Arthritis, Rheu… Rheumatoid Arth… | - - | |||
| NCT00434226 Details | 2009-08-21 Interventional | 2 | 56 | Bevacizumab Carboplatin Paclitaxel Sunitinib Carcinoma, Non-… Lung Neoplasms Non-Small Cell … | Based on data collected, the combination appeared to be poorly tolearated. Based on the early safety results from this study, Genentech halted further recruitment and discontinued treatment. Insufficient efficacy data was available to perform additional analyses and limited the interpretation of the analyses performed. | |||
| NCT00770354 Details | 2009-08-10 Interventional | 2 | - | Letrozole Breast Neoplasm… Breast Carcinom… | - - | |||
| NCT00354900 Details | 2009-08-04 Interventional | 1 | - | Aprotinin Breast Neoplasm… Metastatic Brea… | The FDA changed the labeling for this agent, and we felt we could not offer it to patients on a
non-surgical study. - | |||
| NCT00693004 Details | 2009-07-30 Interventional | 2 | - | Donepezil Alzheimer Disea… Alzheimer's Dis… | - - | |||
| NCT00947375 Details | 2009-07-28 Interventional | 4 | 335 | Haloperidol Haloperidol dec… Lamotrigine Schizophrenia | All of the mentioned aim and objectives were achieved before the February 2007 - | |||
| NCT00532025 Details | 2009-07-28 Interventional | 2 | - | Sorafenib Carcinoma Carcinoma, Non-… Lung Neoplasms | - - | |||
| NCT00602680 2007-001639-80 Details | 2009-07-20 Interventional | 2 | 1 | Donepezil Alzheimer Disea… Alzheimer's Dis… | Insufficient expected benefit risk - | |||
| NCT00434096 Details | 2009-07-20 Interventional | 3 | 915 | Rimonabant Dyslipidemias Obesity | Company decision taken in light of demands by certain national health authorities - | |||
| NCT00610792 Details | 2009-07-14 Interventional | 2 | - | Bortezomib Doxorubicin Liposomal doxor… Carcinoma, Ovar… Ovarian Neoplas… Ovarian Cancer | Study never submitted to IND. Study is being sponsored by Johnson and Johnson in the EU only. - | |||
| NCT00601276 Details | 2009-07-13 Interventional | 3 | - | Cyproterone Cyproterone Ace… Leuprolide Pedophilia | - - | |||
| NCT00314457 Details | 2009-07-13 Interventional | 4 | 16 | Bupivacaine ACL Repair Bankart Repair Meniscectomy | Bupivacaine has recently been shown to inhibit osteoclast formation in vitro. - | |||
| NCT00595985 Details | 2009-07-07 Interventional | 2 | 5 | Sorafenib Stomach Neoplas… Gastric Cancer | low response rate, no evidence of PFS or OS improved. - | |||
| NCT00929370 Details | 2009-06-29 Interventional | 1 | 34 | Glycine Schizophrenia | Study has now been terminated due to changes in project strategy. Current available data will
be analysed and reported in a synoptic study report. - | |||
| NCT00502294 Details | 2009-06-25 Interventional | 3 | - | Visilizumab Colitis Colitis, Ulcera… Ulcer Intravenous Ste… | - - | |||
| NCT00117702 2005-000161-19 Details | 2009-06-18 Interventional | 2/3 | 24 | Everolimus Tacrolimus Graft vs Host D… | safety reasons - | |||
| NCT00678483 2007-002492-14 Details | 2009-06-17 Interventional | 3 | 331 | Rimonabant Overweight Weight Loss Obesity | Company decision taken in light of demands by certain national health authorities - |